Regeneron Pharmaceuticals (REGN) Change in Receivables (2009 - 2026)
Regeneron Pharmaceuticals' Change in Receivables came in at $838.5 million for Q2 2026, compared with $28.2 million a year earlier.
Regeneron Pharmaceuticals (REGN) Change in Receivables (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported Change in Receivables of $968.8 million; for FY2025, it came in at -$498.1 million.
- Going back by year, Change in Receivables was $554 million in FY2024 (+63.5%), $338.8 million in FY2023, -$707.8 million in FY2022 and $1.93 billion in FY2021 (+42.1%).
- The Q2 2026 figure represents the highest quarterly Change in Receivables since Q2 2021.
- Year-over-year, Change in Receivables increased in 1 of the last five quarters, with an average decline of 40.8%.
- The fastest year-over-year change in Change in Receivables over five years came in Q4 2021 (growth of 623.4%), and the weakest in Q2 2023 (a decline of 99.2%).
- Business Quant data shows REGN's Change in Receivables at -$1.2 million (Q1 2026), $51.2 million (Q4 2025) and $80.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 838.50 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 838.50 Mn |
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | 51.20 Mn |
| Sep 30, 2025 | 80.30 Mn |
| Jun 30, 2025 | 28.20 Mn |
| Mar 31, 2025 | -657.80 Mn |
| Dec 31, 2024 | 117.80 Mn |
| Sep 30, 2024 | 388.90 Mn |
| Jun 30, 2024 | 494.10 Mn |
| Mar 31, 2024 | -446.80 Mn |
| Dec 31, 2023 | 82.70 Mn |
| Sep 30, 2023 | 463.50 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | -210.10 Mn |
| Dec 31, 2022 | -219.60 Mn |
| Sep 30, 2022 | 386.90 Mn |
| Jun 30, 2022 | 322.40 Mn |
| Mar 31, 2022 | -1.20 Bn |
| Dec 31, 2021 | 584.50 Mn |
| Sep 30, 2021 | -1.54 Bn |
Regeneron Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=REGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();